CD276 and prostate adenocarcinoma: To assess the impact of ADT on B7-H3 expression in hormone-naive prostate adenocarcinoma, we first analyzed CD276 (B7-H3) mRNA expression level using high-risk PCa clinical cohort with 45 samples from radical prostatectomy.